Clinique Saint Pierre Ottignies

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Heart failure1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Biotronik SE & Co. KG1 trial
• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
• UNICANCER1 trial

Running trials

• Active, not recruiting

  BIO|MASTER.CSP Study

  NCT06620237· Biotronik SE & Co. KG· Source

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

  NCT04053322· Phase 2· UNICANCER· Source